The largest biotech event country based event in Europe
BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (+3.300) and companies participating (+773). 34% of our delegates came from outside of Spain.
Why Spain?
In 2018 there were 751 dedicated biotechnology enterprises in Spain (+5,33%), according to data in the AseBio Report 2019. Biotech companies have generated more than €8.2 billion in income, roughly 0.7% of the national total. The biotechnology sector was responsible for more than 105,000 direct, indirect and induced jobs, which is 0.6% of national employment. Over 27,000 of these jobs were people employed directly by biotech companies. Biotechnology activities are at the top of rankings on production growth of economic activities for 2018, up 10.1%.”
EuropaBio Members can benefit of a 10% discount on the price. Please liaise with Martina Cilia (m.cilia@europabio.org) to receive detailed information on the discount code.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.